The Potential Role of Advanced Glycation End Product and iNOS in Chronic Renal Failure-Related Testicular Dysfunction

Objectives: To investigate the impact of advanced glycation end products (AGEs) and inducible nitric oxide synthase (iNOS) in chronic renal failure (CRF)-associated testicular dysfunction in an experimental model. In additionally, we examined whether different peritoneal dialysis (PD) fluids could contribute to the elevation in AGE level and iNOS expression in the testes. Methods: Adult male Wistar rats, 10 and 12 weeks of age and weighing 200–330 g, were divided into 5 groups. Group 1 served as the control group. In group 2, CRF was induced and a peritoneal catheter was implanted, but the dialysis procedure was not performed until the end of the study. In group 3, CRF was induced and PD was performed with dialysis fluids containing 1.36% glucose and icodextrin. In group 4, CRF rats received dialysis fluids containing 3.86% glucose and icodextrin. Finally, an indwelling catheter was implanted and the dialysis procedure was performed using dialysis fluids containing 3.86% glucose and icodextrin (group 5). Chronic PD began 4 weeks after insertion of the catheter. Each morning, this fluid was drained and 20 ml dialysis fluid, containing either 1.36 or 3.86% glucose, was given intraperitoneally for 4 h in unanesthetized animals. Each evening, 20 ml icodextrin was given for 10 h. The dialysis procedure was performed for 8 weeks. The AGE level was determined from the 5-hydroxymethyl-2-furaldehyde (5-HMF) content of penis samples and iNOS expression was assessed by immunohistochemistry. Results: The elevation of 5-HMF was significant in the testes from groups 2, 3, 4, and 5 when compared with group 1. Furthermore, the differences between groups 2 and 4, 3 and 4, and 4 and 5 were also significant (p < 0.05). Immunohistochemical analysis revealed the presence of iNOS predominantly in the Leydig cells. While iNOS staining was significantly lower in group 1 than in other groups, there were also significant differences between groups 2 and 3, 2 and 4, 2 and 5, 3 and 5, and 4 and 5 (p < 0.05). Finally, a significant statistical correlation was found between the 5-HMF and iNOS levels (r = 0.698, p = 0.001). Conclusions: The present study identifies, for the first time, a potential role of AGE and iNOS in experimental CRF-associated testicular dysfunction. In addition, we found that PD fluids containing glucose contribute to this effect. These results may lead to a better understanding of the pathophysiological pathway in CRF-related testicular dysfunction.

[1]  T. Erdoğru,et al.  Impact of chronic renal failure and peritoneal dialysis fluids on advanced glycation end product and iNOS levels in penile tissue: an experimental study. , 2002, Urology.

[2]  G. Cutroneo,et al.  Nitric oxide synthase patterns in normal and varicocele testis in adolescents , 2001, BJU international.

[3]  V. Monnier,et al.  Effect of chronic aminoguanidine treatment on age-related glycation, glycoxidation, and collagen cross-linking in the Fischer 344 rat. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  T. Miyata,et al.  Reactive carbonyl compounds related uremic toxicity ("carbonyl stress"). , 2001, Kidney international. Supplement.

[5]  M. Fujisawa,et al.  Expression of endothelial nitric oxide synthase in the Sertoli cells of men with infertility of various causes , 2001, BJU international.

[6]  B. Palmer Sexual dysfunction in uremia. , 1999, Journal of the American Society of Nephrology : JASN.

[7]  V. Pitelka,et al.  Nitric oxide is a mediator of the inhibitory effect of activated macrophages on production of androgen by the Leydig cell of the mouse. , 1998, Endocrinology.

[8]  Y. Kubota,et al.  Testicular histology in experimental uremic rats. , 1998, Archives of andrology.

[9]  J. Holley,et al.  Fertility and contraception in end-stage renal disease. , 1998, Advances in renal replacement therapy.

[10]  R. Middendorff,et al.  Evidence for production and functional activity of nitric oxide in seminiferous tubules and blood vessels of the human testis. , 1997, The Journal of clinical endocrinology and metabolism.

[11]  Y. Wada,et al.  Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure. , 1997, Kidney international.

[12]  M. Fujisawa,et al.  Nitric oxide production by cultured rat Leydig cells. , 1997, Endocrinology.

[13]  T. Miyata,et al.  Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[14]  O. Pignataro,et al.  Nitric oxide inhibits Leydig cell steroidogenesis. , 1996, Endocrinology.

[15]  A. Kelkar,et al.  Male reproductive function in uraemia: efficacy of haemodialysis and renal transplantation. , 1996, British journal of urology.

[16]  P. Jungers,et al.  Advanced oxidation protein products as a novel marker of oxidative stress in uremia. , 1996, Kidney international.

[17]  V. Monnier,et al.  Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  V. Monnier,et al.  Early and advanced glycosylation end products. Kinetics of formation and clearance in peritoneal dialysis. , 1996, The Journal of clinical investigation.

[19]  T. Miyata,et al.  Pathophysiology of advanced glycation end-products in renal failure. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[20]  M. Erkılıç,et al.  The effects of streptozocin-induced diabetes on renal plasma flow. , 2009, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[21]  V. Monnier,et al.  Influence of dialysis modality on plasma and tissue concentrations of pentosidine in patients with end-stage renal disease. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[22]  B. Holmquist,et al.  Development of Toxic Degradation Products during Heat Sterilization of Glucose-Containing Fluids for Peritoneal Dialysis: Influence of Time and Temperature , 1995, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.

[23]  J. Baynes,et al.  Glycation, Glycoxidation, and Cross-Linking of Collagen by Glucose: Kinetics, Mechanisms, and Inhibition of Late Stages of the Maillard Reaction , 1994, Diabetes.

[24]  E. Shultz,et al.  Glycosylated serum proteins and glycosylated hemoglobin in the assessment of glycemic control in insulin-dependent and non-insulin-dependent diabetes mellitus. , 1993, Metabolism: clinical and experimental.

[25]  T. Lyons,et al.  Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus. , 1993, The Journal of clinical investigation.

[26]  T. Lyons,et al.  Accumulation of Maillard Reaction Products in Skin Collagen in Diabetes and Aging a , 1992, Annals of the New York Academy of Sciences.

[27]  T. Miller,et al.  Characterization of an animal model of continuous peritoneal dialysis in chronic renal impairment. , 1992, Clinical nephrology.

[28]  K. Tracey,et al.  Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.

[29]  J. Yeung Effects of glycerol-induced acute renal failure on tissue glutathione and glutathione-dependent enzymes in the rat. , 1991, Methods and findings in experimental and clinical pharmacology.

[30]  E. Ford,et al.  Protein glycosylation and collagen metabolism in normal and diabetic rats. , 1989, The Journal of surgical research.

[31]  A. Cerami,et al.  Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.

[32]  David Handelsman Hypothalamic-pituitary gonadal dysfunction in renal failure, dialysis and renal transplantation. , 1985, Endocrine reviews.

[33]  D. Kerrigan,et al.  A MODIFIED JOHNSEN’S COUNT FOR EVALUATION OF SPERMATOGENESIS IN THE RAT , 1985 .

[34]  S. Stohs,et al.  Glycosylated collagen. , 1979, Biochemical and biophysical research communications.

[35]  R. Atkins,et al.  A comparison of hemodialysis and transplantation in reversing the uremic disturbance of male reproductive function. , 1978, Clinical nephrology.

[36]  S. Johnsen Testicular biopsy score count--a method for registration of spermatogenesis in human testes: normal values and results in 335 hypogonadal males. , 1970, Hormones.